Long considered to be the main standard topical treatment for rosacea, Metrogel 1% is the Galderma branded treatment that contains 1% of Metronidazole. Over the years Galderma has brought us Metrogel 0.75%, Metrolotion, Metrocream and now Metrogel 1% Pump 55gm.
Be sure to check out the Metrogel 1% User Reviews and How does Metrogel work?.
Recent Rosacea Blog Posts
A study has been released that headlines a result that even though Soolantra costs more than Finacea, overall it is actually cheaper than Finacea. The study uses a complicated formula to deduce that even though Soolantra sells for more per tube than Finacea, the overall cost versus the benefit you receive shows that Soolantra is […]
This just-published study finds that once your rosacea is under control, Soolantra once a day will likely do a better job at keeping papules and pustules at bay compared to Metrogel 0.75% twice per day. Why not Metrogel 1%? Interestingly this study did not compare Soolantra against Metrogel 1%, but Metrogel 0.75%. The leaves us […]
A recently listed Clinical Trial aims to recruit rosacea sufferers to find out how well they are getting on with their usage of Finacea, Metrogel and Mirvaso. The trial outcomes are several, but include the recording of adverse reactions to treatments, patient satisfaction and likelihood of switching rosacea treatment. The trial is being sponsored by […]
A clinical research company has posted a large clinical trial to compare a Metronidazole 1% Gel to Galderma’s Metrogel 1%. The multi center trial is looking for 947 participants across the US. The manufacturer of the comparison Metronidazole 1% Gel is not mentioned, but a reasonable guess would be Metronidazole Gel from Sandoz. Generic Metronidazole […]
Despite suggestions that Generic Metrogel is easily available in the US, there are scant reports online from users getting access to cheaper Metronidazole 1% treatments. In July this year Sandoz announced that they were selling a generic version of Metrogel 1%. The generic versions of metronidazole gel were previously restricted to 0.75% as the patent […]